Puerto Rico: A Strategic Hub for Bioscience Manufacturing

Choosing a manufacturing or expansion site usually means trading tax advantage for regulatory certainty, or supply-chain reach for talent depth. Puerto Rico is where those tradeoffs collapse: a US jurisdiction under federal law and FDA regulation, with a 4 percent local corporate rate and the highest concentration of pharma and medical device talent in the country.

This brief from Invest Puerto Rico shows why the island is the only US jurisdiction leading 4 of the 5 bioscience subsectors, and how its Foreign Trade Zone, FDA-approved plant footprint, and R&D incentives support companies setting up or scaling production.

Download it to see how Puerto Rico fits your next site-selection decision.

First name

Last name

Business Email Address

Company name

Company Type

Job title

Job Function

Country

Work Phone Number

By submitting this content request, I have legitimate interest in the content and agree that Invest Puerto Rico, their partners, and the creators of any other content I have selected may contact me regarding news, products, and services that may be of interest to me.

Yes No

Are you evaluating locations for expansion?

Timeline for potential expansion

I acknowledge and agree to the use of my contact information to receive messages about offerings by Questex, its brands, affiliates and/or third-party partners, consistent with Questex Privacy Policy